The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $2.58 in the prior trading day, Nuvation Bio Inc (NYSE: NUVB) closed at $2.60, up 0.78%. In other words, the price has increased by $0.78 from its previous closing price. On the day, 1.67 million shares were traded. NUVB stock price reached its highest trading level at $2.77 during the session, while it also had its lowest trading level at $2.51.
Ratios:
Our goal is to gain a better understanding of NUVB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 44.11 and its Current Ratio is at 44.11. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 27, 2024, Upgraded its rating to Buy and sets its target price to $10 from $1.40 previously.
On March 26, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $5.
Jefferies Downgraded its Buy to Hold on January 06, 2023, whereas the target price for the stock was revised from $5 to $2.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NUVB now has a Market Capitalization of 641495360 and an Enterprise Value of -37685832.
Stock Price History:
Over the past 52 weeks, NUVB has reached a high of $4.16, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is 6.79%, while the 200-Day Moving Average is calculated to be 50.53%.
Shares Statistics:
The stock has traded on average 1.29M shares per day over the past 3-months and 1151510 shares per day over the last 10 days, according to various share statistics. A total of 218.05M shares are outstanding, with a floating share count of 134.69M. Insiders hold about 38.51% of the company’s shares, while institutions hold 54.16% stake in the company. Shares short for NUVB as of 1711584000 were 3006181 with a Short Ratio of 2.33, compared to 1709164800 on 2647347. Therefore, it implies a Short% of Shares Outstanding of 3006181 and a Short% of Float of 2.53.
Earnings Estimates
Nuvation Bio Inc (NUVB) is currently under the scrutiny of NUVERA COMMUNICATIONS INC analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $2.60, with high estimates of $0.00 and low estimates of $62.76.
